iBio (IBIO) EBITDA Margin Growth (1y) (2012 - 2025)
iBio (IBIO) EBITDA Margin Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1,552.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -65,100.00 |
| Mar 31, 2022 | 56,446.00 |
| Sep 30, 2021 | -453,146.00 |
| Jun 30, 2021 | -166,089.00 |
| Mar 31, 2021 | 329,176.00 |
| Dec 31, 2020 | -6,544.00 |
| Sep 30, 2020 | 188,066.00 |
| Jun 30, 2020 | 24,829.00 |
| Mar 31, 2020 | -351,796.00 |
| Dec 31, 2019 | -38,803.00 |
| Sep 30, 2019 | 520,833.00 |
| Jun 30, 2019 | 382,645.00 |
| Mar 31, 2019 | 376,284.00 |
| Dec 31, 2018 | 162,313.00 |
| Sep 30, 2018 | -602,286.00 |
| Jun 30, 2018 | -171,109.00 |
| Mar 31, 2018 | 615,963.00 |
| Dec 31, 2017 | 219,346.00 |
| Sep 30, 2017 | -41,862.00 |
| Jun 30, 2017 | -162,372.00 |